Literature DB >> 9864932

A patient homozygous for mutation 20210A in the prothrombin gene with venous thrombosis and transient ischemic attacks of thrombotic origin.

A J González Ordóñez, J M Medina Rodriguez, C R Fernández Alvarez, M D Macias Robles, E Coto García.   

Abstract

It is well established that genetic disorders interact with environmental factors to cause thrombotic diseases. Therefore, antithrombin, protein C, protein S deficiencies and the more recently described factor V Leiden and prothrombin mutations are currently been investigated to explain some thrombophilic states. We report the case of a 63-year-old man who developed two transient ischemic attacks and two years later an extensive femoro-iliac venous thrombosis. He was genotyped as FV R506Q negative and FII G20210A positive in homozygous state (FII 20210AA).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9864932

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  4 in total

Review 1.  Phenotypic Heterogeneity in Patients with Homozygous Prothrombin 20210AA Genotype. A paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.

Authors:  David Bosler; Joan Mattson; Domnita Crisan
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

2.  Bilateral Superficial Femoral Artery Thrombosis in a 15-Year-Old Caucasian Male with Homozygous Prothrombin G20210A Genotype and Associated Antiphospholipid Syndrome.

Authors:  Uzung Yoon; LaiLai Kwok; Ingo Flessenkaemper
Journal:  Int J Angiol       Date:  2015-03-23

Review 3.  Prothrombin G20210A Gene Mutation-Induced Recurrent Deep Vein Thrombosis and Pulmonary Embolism: Case Report and Literature Review.

Authors:  Sherif Elkattawy; Ramez Alyacoub; Kerry S Singh; Hardik Fichadiya; William Kessler
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

4.  Atypical erythrocytes and platelets in a patient with a pro-thrombin mutation.

Authors:  Etheresia Pretorius; Natasha Vermeulen; Janette Bester
Journal:  Platelets       Date:  2013-10-08       Impact factor: 3.862

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.